| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
253 |
221 |
$24K |
| 80050 |
General health panel |
331 |
328 |
$10K |
| 80061 |
Lipid panel |
637 |
636 |
$7K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
273 |
270 |
$7K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
165 |
164 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
159 |
158 |
$6K |
| 86480 |
|
155 |
152 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
245 |
241 |
$3K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
512 |
496 |
$3K |
| 80053 |
Comprehensive metabolic panel |
377 |
368 |
$3K |
| 86780 |
|
278 |
272 |
$3K |
| 87522 |
Neg quan hep c or qual rna |
80 |
80 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
434 |
434 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,458 |
1,388 |
$3K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
122 |
122 |
$2K |
| 86803 |
|
226 |
223 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
42 |
41 |
$2K |
| 82607 |
|
147 |
144 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
217 |
212 |
$1K |
| 86704 |
|
105 |
105 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
236 |
225 |
$1K |
| 81001 |
|
277 |
269 |
$720.32 |
| 86705 |
|
68 |
68 |
$709.64 |
| 85027 |
|
125 |
124 |
$672.37 |
| 84439 |
|
86 |
84 |
$650.56 |
| 86706 |
|
76 |
75 |
$548.78 |
| 82728 |
|
45 |
45 |
$513.90 |
| 82746 |
|
58 |
55 |
$513.66 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
28 |
20 |
$487.50 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
13 |
13 |
$382.46 |
| 84460 |
|
83 |
82 |
$368.75 |
| 84450 |
|
82 |
81 |
$355.30 |
| 83540 |
|
57 |
57 |
$305.37 |
| 80076 |
|
52 |
52 |
$305.06 |
| 84075 |
|
67 |
67 |
$291.01 |
| 82247 |
|
67 |
67 |
$282.29 |
| 84403 |
|
13 |
12 |
$281.45 |
| 87340 |
|
26 |
26 |
$234.27 |
| 84155 |
|
67 |
67 |
$205.86 |
| 82040 |
|
66 |
66 |
$192.87 |
| 86618 |
|
12 |
12 |
$169.08 |
| 84481 |
|
26 |
26 |
$121.42 |
| 82570 |
|
25 |
25 |
$117.18 |
| 83550 |
|
12 |
12 |
$87.96 |
| 82043 |
|
13 |
13 |
$58.20 |
| 82248 |
|
12 |
12 |
$50.52 |
| 85652 |
|
13 |
12 |
$29.50 |